Press Releases

New diagnoses of six major cancer types in the United States fell abruptly in early 2020, coinciding with the start of the COVID-19 pandemic, according to findings from part 2 of the latest Annual Report to the Nation on the Status of Cancer.

Today, the American Cancer Society expanded its impact on pediatric patients with cancer through the launch of ACS PAWS (Pups Assisting with Support).

Dr. Robin Yabroff, scientific vice president, health services research at the American Cancer Society (ACS), was named a Fellow of the American Society of Clinical Oncology (FASCO).

The study showed that 55% of CRC patients in SSA survived two years after a diagnosis of their disease, compared to 84% of patients in the United States, and the risk of dying from CRC was 67% higher in patients diagnosed in low-income countries than those diagnosed in middle-income countries.

A new study from researchers at the American Cancer Society found that Black cancer survivors in the United States experience a higher risk of developing cardiovascular disease (CVD) compared with White cancer survivors.

WASHINGTON D.C. – July 20, 2023 – Yesterday, First Lady Dr. Jill Biden held a call with cancer advocacy organizations to discuss the administration’s commitment to increase access to patient...

WASHINGTON, D.C. – July 14, 2023 – The Center for Medicare and Medicaid Services (CMS) released the proposed Calendar Year 2024 Medicare Physician Fee Schedule late yesterday, including coding...

ATLANTA, July 13, 2023 – Today, the International Agency for Research on Cancer (IARC), the research arm of the World Health Organization (WHO), classified aspartame as a possible carcinogen to...

The American Cancer Society strongly believes that today’s Supreme Court’s ruling on affirmative action must not erase the years of progress that has been made to improve diversity within the U.S. medical student population.

In a new study by researchers at the American Cancer Society, Medicaid expansion under the Affordable Care Act was associated with an increased receipt of timely, guideline-based treatment and improved two-year survival among young women newly diagnosed with stage I-III breast cancer.